CD163 and breast carcinoma: Medrek and colleagues relied on visual scoring of CD163+ cells in breast cancer into 4 ordinal categories ranging from 0 (none/absent) up to 3 (strong/dense) and found that infiltration of CD163+ macrophages into tumor stroma, but not into tumor nests, had significant association with overall survival in a cohort of 144 patients [36].